Vestmark Advisory Solutions’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Sell
67,962
-45,026
-40% -$1.73M 0.04% 330
2025
Q1
$4.38M Buy
112,988
+63,154
+127% +$2.45M 0.11% 228
2024
Q4
$1.69M Buy
49,834
+10,310
+26% +$349K 0.06% 278
2024
Q3
$1.62M Buy
39,524
+1,186
+3% +$48.5K 0.06% 262
2024
Q2
$1.48M Buy
38,338
+961
+3% +$37K 0.06% 275
2024
Q1
$1.6M Buy
37,377
+505
+1% +$21.6K 0.07% 264
2023
Q4
$1.37M Sell
36,872
-1,184
-3% -$43.9K 0.07% 260
2023
Q3
$1.38M Sell
38,056
-11,950
-24% -$433K 0.1% 215
2023
Q2
$1.78M Buy
50,006
+7,484
+18% +$267K 0.07% 338
2023
Q1
$1.51M Buy
42,522
+15,122
+55% +$538K 0.07% 340
2022
Q4
$963K Sell
27,400
-1,339
-5% -$47.1K 0.05% 427
2022
Q3
$846K Buy
28,739
+8,285
+41% +$244K 0.05% 421
2022
Q2
$1.11M Buy
20,454
+616
+3% +$33.5K 0.06% 342
2022
Q1
$1.08M Buy
19,838
+10,185
+106% +$554K 0.06% 338
2021
Q4
$532K Hold
9,653
0.03% 527
2021
Q3
$461K Buy
9,653
+47
+0.5% +$2.25K 0.03% 516
2021
Q2
$478K Sell
9,606
-376
-4% -$18.7K 0.03% 489
2021
Q1
$445K Sell
9,982
-2,952
-23% -$132K 0.04% 468
2020
Q4
$595K Sell
12,934
-4,837
-27% -$223K 0.07% 318
2020
Q3
$836K Sell
17,771
-1,975
-10% -$92.9K 0.11% 246
2020
Q2
$1.01M Sell
19,746
-667
-3% -$34K 0.16% 181
2020
Q1
$967K Sell
20,413
-4,102
-17% -$194K 0.19% 163
2019
Q4
$1.44M Sell
24,515
-1,137
-4% -$66.8K 0.3% 120
2019
Q3
$1.37M Sell
25,652
-1,653
-6% -$88.2K 0.22% 140
2019
Q2
$1.37M Buy
27,305
+1,407
+5% +$70.4K 0.23% 134
2019
Q1
$1.35M Buy
+25,898
New +$1.35M 0.24% 126